1. Introduction {#sec1-ijerph-15-02329}
===============

Migrant populations often come from or travel through low- and middle-income countries where the prevalence and burden of infectious diseases differs from the European Union/European Economic Area (EU/EEA) \[[@B1-ijerph-15-02329]\]. Migrant populations include immigrants, refugees, asylum-seekers, displaced persons, undocumented migrants, and other foreign-born residents. In the EU/EEA, for example, subgroups of migrants have a higher prevalence of HIV, tuberculosis (TB), hepatitis B (HBV), and hepatitis C (HCV), and have lower rates of childhood vaccinations compared to native-born populations \[[@B1-ijerph-15-02329]\].

Evidence-based guidelines can direct public health and healthcare practitioners in the screening and treatment of such diseases. These guidelines include information on testing and vaccination and may also consider culturally sensitive ways to approach migrants. For example, existing guidelines for HIV among migrant populations \[[@B2-ijerph-15-02329],[@B3-ijerph-15-02329],[@B4-ijerph-15-02329]\] synthesize evidence on benefits, harms and cost effectiveness, and also provide some interpretation on qualitative data relevant to HIV related stigma and strategies to link patients for treatment. To implement public health guidelines, an understanding of migrant populations' perceptions and fears is needed \[[@B5-ijerph-15-02329]\]. Thus, to ethically offer interventions, we need to understand the perspective of migrants regarding the acceptability of interventions, value placed on outcomes, and accessibility of screening and treatment of infectious disease interventions in the EU/EEA \[[@B6-ijerph-15-02329],[@B7-ijerph-15-02329]\].

The acceptability of infectious disease interventions influences the readiness of migrants and clinicians to incorporate guidelines into practice, as seen in the case of HIV screening \[[@B8-ijerph-15-02329]\]. Insufficient knowledge among clinicians about the acceptability of interventions may inhibit them from offering screening to migrants \[[@B9-ijerph-15-02329]\]. How patients value the disease-related outcomes of interventions (e.g., perception of risk of disease, diagnoses, symptoms, or disease resolution), or other outcomes (e.g., time away from work, stigma, side effects, or adverse events) can create barriers to the uptake of guideline recommendations \[[@B5-ijerph-15-02329]\]. For example, one qualitative study on developing decision aids for HIV testing for newly arrived Sub-Saharan African women to Canada demonstrated how the provision of accurate HIV information can reduce stress \[[@B10-ijerph-15-02329]\]. Existing strategies to improve access to healthcare for migrants include support for transportation, interpreters, and cultural brokers \[[@B11-ijerph-15-02329]\].

The objective of this study is to understand the acceptability, the value placed on outcomes and the accessibility of infectious disease interventions and other health services among recently arrived EU/EEA migrants. We focused specifically on tuberculosis, HIV, HBV, HCV, vaccine-preventable diseases (VPD), and parasitic diseases; diseases that were selected during an ECDC consensus meeting in Stockholm \[[@B12-ijerph-15-02329]\]. We also aimed to explore how the GRADE CERQual tool can appraise qualitative research on implementation considerations.

2. Materials and Methods {#sec2-ijerph-15-02329}
========================

2.1. Search Strategy and Selection Criteria {#sec2dot1-ijerph-15-02329}
-------------------------------------------

We conducted a systematic review of qualitative reviews, and adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) reporting guideline \[[@B13-ijerph-15-02329]\]. A team of experts with qualitative research expertise developed a protocol that considered implementation for public health interventions relevant to migrant populations in EU/EEA. We registered the protocol on Prospero (CRD42016045798) and published our detailed review methods in BMJ Open \[[@B12-ijerph-15-02329],[@B14-ijerph-15-02329]\].

We searched MEDLINE, MEDLINE In-Process, MEDLINE Ahead of Print, EMBASE, CINAHL, DARE, and CDSR for articles published between 1 January 2010 and 29 July 2016. The full search strategy is provided in [Supplementary File S1](#app1-ijerph-15-02329){ref-type="app"}. We also searched grey literature for published reports that met our inclusion criteria from the CDC, ECDC, UNAIDS, EU, and WHO, and scanned references to identify additional qualitative systematic reviews. We included qualitative systematic reviews that reported on values, perceptions on access, and acceptability of infectious disease interventions (see [Appendix A](#app2-ijerph-15-02329){ref-type="app"}). We restricted our inclusion to studies published in English. We included reviews if search and selection strategy methods were explicitly provided, and if the review included qualitative evidence. We focused on migrant and forcibly displaced populations, including children, adolescents, pregnant women, and adults. See [Appendix B](#app3-ijerph-15-02329){ref-type="app"} for full inclusion and exclusion criteria.

2.2. Study Selection and Data Extraction {#sec2dot2-ijerph-15-02329}
----------------------------------------

Three independent team members (MD, MS, TS) screened title and abstracts in duplicate, followed by full-text assessments for eligibility. Conflicts were resolved through discussion or the involvement of a fourth reviewer (AM). Data were downloaded into EndNote reference software \[[@B15-ijerph-15-02329]\]. We assessed the methodological quality of included reviews using the Assessing Methodological Quality of Systematic Reviews tool (AMSTAR) \[[@B16-ijerph-15-02329]\] but did not exclude any studies based on quality.

The same team members extracted data from the included reviews in duplicate. We used a calibration exercise prior to data extraction and discrepancies were resolved through discussion. We designed our data extraction form using the Jacob's accessibility framework \[[@B17-ijerph-15-02329]\]. The Jacob's accessibility framework highlights barriers to accessing health services from both the supply and demand side, and as such recognizes that determinants of geographic accessibility, acceptability, availability, and affordability play a critical role in access. The framework focusses more on accessibility rather than appraising the acceptability and attitudes towards these services. However, adapting this framework to create an inclusive data extraction form (see [Appendix C](#app4-ijerph-15-02329){ref-type="app"}) allowed us to capture all relevant data, which was subsequently contextualized with respect to our research objectives.

2.3. Data Synthesis {#sec2dot3-ijerph-15-02329}
-------------------

We contextualized the preliminary findings on migrant populations using the Health Belief Model framework (HBM) \[[@B18-ijerph-15-02329]\]. The HBM is a commonly used model of the beliefs, expectations, and values that underlie preventive health behavior \[[@B19-ijerph-15-02329]\], and was therefore selected for its clear alignment with our stated research objectives involving the values and acceptability of interventions. HBM suggests that six factors predict health behavior: perceived susceptibility, perceived severity, benefits to action, barriers to action, self-efficacy, and cues to action \[[@B18-ijerph-15-02329]\].

We applied a qualitative lens considering saturation (200 studies were identified within the reviews) and triangulation of data between different diseases, migrant populations, and destination countries to identify preliminary findings. We consulted clinicians (KP, MP, DG, CG) with expertise and experience in migrant health to identify and corroborate the credibility, transferability, confirmability, and dependability to establish the trustworthiness of these findings. Of note, while many reviews discussed how knowledge of risk factors influences health behavior, only two reviews \[[@B20-ijerph-15-02329],[@B21-ijerph-15-02329]\] commented specifically on how susceptibility, in itself, determines health behavior, which is how "perceived susceptibility" is classically theorized in the HBM \[[@B18-ijerph-15-02329]\]. Given the strong cognitive component of susceptibility within the HBM \[[@B22-ijerph-15-02329]\], we opted to include the knowledge data in our main findings, yet we typified this as "knowledge of risk factors" to maintain accuracy.

Five of the 12 preliminary findings were selected as "key findings" to be further analyzed with the Confidence in the Evidence from Reviews of Qualitative research (CERQual) tool. These were selected by consensus among three authors (MD, KP, AM), based on their respective strength of evidence, the number of reviews supporting the finding, the level of variability in review findings, and the significance of the findings as stated in the included reviews.

We used the CERQual tool to assess the confidence of our findings. CERQual is a new method for assessing the confidence of qualitative review evidence, similar to how the GRADE approach assesses the certainty of quantitative evidence \[[@B23-ijerph-15-02329]\]. CERQual bases this evaluation on four criteria: (a) methodological limitations of included studies supporting a review finding, (b) the relevance of included studies to the review question, (c) the coherence of the review finding, and (d) the adequacy of the data contributing to a review finding. To our knowledge, CERQual has not been used in a review of reviews to date. To apply the principles of CERQual to a review of reviews, we needed to make minor adjustments, such as considering the number of primary studies within a given review to assess the adequacy criterion.

3. Results {#sec3-ijerph-15-02329}
==========

3.1. Study Selection {#sec3dot1-ijerph-15-02329}
--------------------

The formal search identified 2108 articles. Reference scanning identified three additional reviews. We screened 87 full-text articles and 11 qualitative systematic reviews met our inclusion criteria. All reviews examined populations migrating from low- and middle-income countries to high-income countries. See PRISMA Flow Sheet showing selection, [Figure 1](#ijerph-15-02329-f001){ref-type="fig"}.

Three of the systematic reviews focused exclusively on migrant populations \[[@B24-ijerph-15-02329],[@B25-ijerph-15-02329],[@B26-ijerph-15-02329]\]. Other reviews examined migrant populations as subgroups within the general populations \[[@B21-ijerph-15-02329],[@B27-ijerph-15-02329],[@B28-ijerph-15-02329]\]. The host population countries were predominantly in Western Europe and the United States. Participants mostly consisted of Latino, Hispanic, or sub-Saharan African migrants, but also included South-East Asian and Middle-Eastern migrants. Most reviews included both quantitative data from cohort and cross-sectional studies as well as qualitative data from focus groups and interviews. Three reviews focused on HIV, three on HBV/HCV, and five on TB. No reviews specifically addressed vaccine-preventable or parasitic diseases. See characteristics of included studies in [Table 1](#ijerph-15-02329-t001){ref-type="table"}.

3.2. Methodological Quality {#sec3dot2-ijerph-15-02329}
---------------------------

We assessed methodological quality using the AMSTAR tool. AMSTAR was originally designed for quantitative reviews but many of the criteria are applicable to qualitative reviews, such as, a priori design, duplicate selection, comprehensive search, criteria, and characteristics of included and excluded studies and consideration of scientific quality. The authors have used AMSTAR for qualitative systematic reviews \[[@B33-ijerph-15-02329],[@B34-ijerph-15-02329]\]. AMSTAR scores were distributed fairly evenly between one and seven points out of a possible 11, with a median score of 2/11. AMSTAR items varied significantly with respect to the proportion of reviews meeting that item.

3.3. Migrants' Perceptions of Acceptability {#sec3dot3-ijerph-15-02329}
-------------------------------------------

We organized the findings using the Health Beliefs Model (HBM) \[[@B19-ijerph-15-02329]\]. Through our framework analysis, we identified 12 preliminary findings from the data. See [Table 2](#ijerph-15-02329-t002){ref-type="table"} for a detailed description of these findings.

Three reviews reported on acceptability of interventions \[[@B25-ijerph-15-02329],[@B26-ijerph-15-02329],[@B28-ijerph-15-02329]\]. Tomas et al. found that the TB screening process was generally well-received among migrants \[[@B26-ijerph-15-02329]\]. According to Mitchell et al. \[[@B28-ijerph-15-02329]\], the overall acceptability of TB screening among migrants was considered to be high, yet migrants' perception of TB as a severe disease was associated with screening refusal. Owiti et al., reported that some migrants expressed motivation to or actively sought screening for HBV/HCV, and that certain populations were receptive to HBV vaccination \[[@B25-ijerph-15-02329]\].

Furthermore, peer support and the influence of family members promotes self-efficacy in seeking healthcare and improves the acceptability of interventions, yet there are also instances in which these social connections may introduce other barriers \[[@B20-ijerph-15-02329],[@B24-ijerph-15-02329],[@B25-ijerph-15-02329]\]. For example, family support would improve adherence to TB treatment, but the need for women, at times, to request their partner's approval to seek screening acted as a barrier \[[@B20-ijerph-15-02329],[@B24-ijerph-15-02329]\]. Cultural and family beliefs that differ from those of the host nation may present a perceived barrier, and may lead to other barriers, such as disease-related stigma, that can influence acceptability of care \[[@B21-ijerph-15-02329],[@B26-ijerph-15-02329],[@B27-ijerph-15-02329],[@B30-ijerph-15-02329],[@B31-ijerph-15-02329],[@B32-ijerph-15-02329]\]. In addition, various attitudes towards an intervention itself, especially side effects and cultural taboos, may influence its acceptability among migrants \[[@B24-ijerph-15-02329],[@B26-ijerph-15-02329],[@B27-ijerph-15-02329]\].

The patient-practitioner relationship was consistently emphasized as an important cue to action in seeking further care. Trust, cultural sensitivity, and communication skills can greatly improve the acceptability of infectious disease interventions \[[@B20-ijerph-15-02329],[@B25-ijerph-15-02329],[@B26-ijerph-15-02329],[@B27-ijerph-15-02329],[@B28-ijerph-15-02329],[@B29-ijerph-15-02329],[@B30-ijerph-15-02329],[@B31-ijerph-15-02329]\]. Therefore, recommendations from healthcare practitioners can influence migrants' health seeking behavior \[[@B25-ijerph-15-02329],[@B30-ijerph-15-02329],[@B31-ijerph-15-02329]\].

Social determinants also influenced the acceptability of interventions. The number of years of formal education was positively correlated with HIV screening \[[@B21-ijerph-15-02329],[@B24-ijerph-15-02329]\], HBV/HCV knowledge, \[[@B25-ijerph-15-02329]\] testing and vaccination \[[@B30-ijerph-15-02329]\] and TB screening and treatment \[[@B27-ijerph-15-02329]\]. In one review, older age was associated with HBV/HCV knowledge \[[@B25-ijerph-15-02329]\], but another review, among Asian Americans/Pacific Islanders \[[@B30-ijerph-15-02329]\] showed younger age was associated with HBV/HCV knowledge. Gender also played a role, as females were more receptive to HIV screening \[[@B20-ijerph-15-02329],[@B24-ijerph-15-02329]\], but males were more likely to be screened for HBV \[[@B30-ijerph-15-02329],[@B31-ijerph-15-02329]\].

3.4. Migrants' Values on Outcomes of Interventions {#sec3dot4-ijerph-15-02329}
--------------------------------------------------

Traditional beliefs of migrants may play a role in the value placed on outcomes of infectious disease interventions. The reviews report that migrants' perceived severity of and susceptibility to infectious diseases influences their uptake of testing and treatment interventions. Reviews of TB, HIV and hepatitis reported a low level of western knowledge and understanding of risk factors and transmission of disease among migrants, and this may make them less likely to seek screening, vaccination, or treatment \[[@B20-ijerph-15-02329],[@B21-ijerph-15-02329],[@B24-ijerph-15-02329],[@B25-ijerph-15-02329],[@B27-ijerph-15-02329],[@B29-ijerph-15-02329],[@B30-ijerph-15-02329],[@B31-ijerph-15-02329]\]. While the degree of knowledge varied among studies, it was consistently associated with the uptake of interventions.

Migrants reported certain perceived benefits as valued outcomes of screening, vaccination, and treatment. The most consistently valued outcomes included reassurance of disease-free status and thus prevention of transmission to others \[[@B21-ijerph-15-02329],[@B24-ijerph-15-02329],[@B26-ijerph-15-02329],[@B30-ijerph-15-02329]\]. Uptake of interventions was associated with perceptions of negative disease-related outcomes among migrants. Stigma, and its related connotation, acts as a large barrier to screening and treatment \[[@B20-ijerph-15-02329],[@B21-ijerph-15-02329],[@B24-ijerph-15-02329],[@B25-ijerph-15-02329],[@B26-ijerph-15-02329],[@B27-ijerph-15-02329],[@B29-ijerph-15-02329],[@B32-ijerph-15-02329]\]. Indirect costs, such as loss of employment and loss of migration status and social status, reduced the value placed on interventions \[[@B20-ijerph-15-02329],[@B24-ijerph-15-02329],[@B25-ijerph-15-02329],[@B29-ijerph-15-02329],[@B32-ijerph-15-02329]\]. For example, certain migrants feared that a positive test result would have a negative impact on their immigration status or refugee claim. Symptoms were consistently reported as an important cue for health actions; for example, migrants value screening or treatment of symptomatic diseases over asymptomatic diseases and often wait until they are symptomatic before seeking care \[[@B24-ijerph-15-02329],[@B26-ijerph-15-02329],[@B29-ijerph-15-02329],[@B30-ijerph-15-02329],[@B31-ijerph-15-02329]\].

3.5. Accessibility of Health Services {#sec3dot5-ijerph-15-02329}
-------------------------------------

Barriers to accessibility were reported at both structural and community levels. Structural barriers to care for migrants include cultural and language barriers \[[@B35-ijerph-15-02329]\], inadequate practitioner cultural competencies \[[@B36-ijerph-15-02329]\], disease-related stigma and discrimination \[[@B20-ijerph-15-02329]\], perceptions of health and healthcare \[[@B37-ijerph-15-02329]\], and legal status of migrants \[[@B24-ijerph-15-02329]\]. Community-level barriers include the availability and awareness of services such as transportation, economic barriers including healthcare coverage and cost of services, and policy barriers such as the healthcare system capacity and coverage. These barriers interact with poverty, inequality, and power, further exacerbating the poor health of the migrants \[[@B38-ijerph-15-02329]\]. Time spent accessing healthcare can incur a significant opportunity cost for migrants, especially when they have insecure employment or cannot meet basic needs during their settlement process \[[@B20-ijerph-15-02329],[@B24-ijerph-15-02329],[@B26-ijerph-15-02329],[@B27-ijerph-15-02329],[@B28-ijerph-15-02329],[@B29-ijerph-15-02329]\]. Furthermore, barriers related to the migration process, including language proficiency, cultural barriers, and navigation of the healthcare system, can make interventions less acceptable or accessible for migrants \[[@B20-ijerph-15-02329],[@B21-ijerph-15-02329],[@B24-ijerph-15-02329],[@B25-ijerph-15-02329],[@B26-ijerph-15-02329],[@B27-ijerph-15-02329],[@B29-ijerph-15-02329],[@B30-ijerph-15-02329]\]. While interpreters may improve accessibility, their presence may introduce new potential barriers surrounding confidentiality \[[@B24-ijerph-15-02329],[@B26-ijerph-15-02329],[@B30-ijerph-15-02329]\].

3.6. Confidence in Findings {#sec3dot6-ijerph-15-02329}
---------------------------

We analyzed the confidence of our five findings using CERQual (see [Table 3](#ijerph-15-02329-t003){ref-type="table"}). Three findings were assigned a moderate confidence rating, and two were assigned a low confidence rating. See [Table 4](#ijerph-15-02329-t004){ref-type="table"} for a detailed explanation of confidence ratings.

4. Discussion {#sec4-ijerph-15-02329}
=============

We identified 11 systematic reviews that addressed factors influencing acceptability, the value placed on outcomes, and accessibility of screening and treatment of infectious diseases among migrants. Using the framework of the Health Belief Model, we found factors that influenced healthcare engagement and intervention uptake in each disease group, i.e., TB, HIV, HBV, and HCV. This analysis supports the role of the HBM in identifying and organizing implementation considerations in public health guidelines for migrants. We also assessed the confidence in five key findings using the CERQual tool. Three findings were rated as moderate confidence, and two were rated as low confidence (See GRADE CERQual [Table 4](#ijerph-15-02329-t004){ref-type="table"}).

The findings of this review suggest that disease-related stigma, and inaccurate knowledge related to certain infectious diseases, continue to be major deterrents for screening among migrants. However, ongoing education of migrant patients and their physicians may increase adherence to TB screening and treatment \[[@B27-ijerph-15-02329]\]. Stigma relates to traditional and western beliefs concerning disease outcomes, and these beliefs interact with longstanding cultural and social barriers \[[@B37-ijerph-15-02329]\]. Stigma can manifest in family and community life and may impact employment as well as healthcare. Addressing stigma will require a multi-faceted approach that involves engagement of affected communities as well as efforts to reduce structural barriers \[[@B24-ijerph-15-02329]\], as exemplified by the integration efforts taking place in Germany \[[@B39-ijerph-15-02329]\].

Migrant populations face screening at the political, public health and primary health care levels. We found that migrants consider the indirect costs that potentially accompany disease results, such as loss of employment and loss of migration status and social status. These negative outcomes may vary across the EU/EEA. On the contrary, migrants value screening, post hoc, when they do not have a disease.

Migrants consistently identify trust in practitioners as a key determinant to accepting infectious disease interventions \[[@B40-ijerph-15-02329]\]. Various organizations have developed cultural competency \[[@B41-ijerph-15-02329]\], cultural humility \[[@B42-ijerph-15-02329]\] programs to build trust for newly arrived migrants. In the context of cultural sensitivity, practitioners' approach may play an important role for linkage to care for migrants. More research, including participatory research, is needed to engage migrants in implementation strategies \[[@B43-ijerph-15-02329],[@B44-ijerph-15-02329]\]. For example, one qualitative study used interviews with migrant leaders in community health to not only identify barriers to disease screening, but also identify innovative approaches to mitigate barriers by combining screening for all relevant diseases into one standardized check-up, thereby improving accessibility and further reducing disease-related stigma \[[@B45-ijerph-15-02329]\].

4.1. Implications for Practice {#sec4dot1-ijerph-15-02329}
------------------------------

The qualitative data from our 11 reviews reports a compelling story of migrant access to care issues and acceptability issues related to stigma, indirect costs, and health system barriers. When migrants experienced disease symptoms or were able to perceive benefits from screening and/or trusted their practitioners, they were more likely to value, accept, and access infectious disease interventions. These findings tap into the lived experience of many migrants and may have relevance for screening programs; however, these findings cannot be generalized across all populations and diseases.

4.2. Strengths and Limitations {#sec4dot2-ijerph-15-02329}
------------------------------

Traditionally, the GRADE CERQual tool is used to assess confidence in the evidence of synthesized qualitative studies. This paper is the first to adapt the CERQual tool to assess the confidence of systematic review level qualitative evidence. We also directed our findings and applied our confidence ratings as evidence in the ECDC Guidance development process, including values on intervention outcomes and acceptability of screening and treatment interventions of infectious diseases among migrant populations. These findings were implemented into evidence to decision tables and helped to develop ECDC guidance and implementation considerations for migrants.

According to the AMSTAR scores, the quality of eligible systematic reviews was low, highlighting a need for more rigorous evidence on the acceptability and accessibility of interventions among migrants. Specifically, the methods used to combine findings were generally appropriate, yet only two reviews \[[@B24-ijerph-15-02329],[@B29-ijerph-15-02329]\] assessed and documented the quality of the primary studies included. While this may impact the validity of our findings, we demonstrated how the CERQual methodology can be used to account for the quality of the included reviews to generate sound assessments of the strength of qualitative evidence.

Our systematic review of reviews approach allowed us to use data that summarized findings from over 200 primary studies and supported the assessment of adequacy, consistency, and coherence. However, this approach also created some methodological challenges. We were obliged to report the findings without additional interviews and triangulation. Second, while we used the number of reviews and primary studies supporting a finding as evidence for the robustness of a finding, the precise relevance of these findings varied.

We began with six infectious disease interventions, which were consistent with those prioritized by the EU/EEA guidance work. This allowed us to consider consistencies across different individual diseases and provided more data to synthesize into findings. However, examining the data in aggregate may mask differences between these diseases. For example, most of the evidence on stigma comes from reviews on HIV and TB, and thus may not be generalizable to HBV or HCV or diseases not represented in the included reviews. We were unable to find qualitative systematic reviews that addressed vaccine-preventable diseases or intestinal parasites. While some of the evidence is likely relevant to these diseases, we accept that some of the barriers may be different. For example, VPDs are likely more relevant for migrant children and parents/caregivers, for whom the barriers and facilitators differ from adult migrants.

We were able to look at the findings from various migrant population and destination country perspectives. We chose to group the priority infectious diseases together, demonstrating that migrant perspectives varied across these diseases. We were unable to effectively rule out outliers on all the priority conditions and our findings are more aligned with migrant populations than destination countries.

5. Conclusions {#sec5-ijerph-15-02329}
==============

Our review highlights migrants' perspectives on screening and treatment of infectious diseases, and as such, provides insight as to why migrants may accept or reject screening and treatment. Addressing disparities in prevalence and treatment rates of diseases between and within migrant populations will require implementation strategies that address migrant and practitioner knowledge, fear, and access barriers to health services. The acceptability, value of main outcomes and accessibility of screening and treatment interventions among migrants is highly dependent on the cultural sensitivity, relationship with healthcare professionals, disease-related stigma, and the degree of knowledge and self-perceived risk of diseases. Migrants may fear negative outcomes of screening including indirect costs related to the employment and immigration status, and they value screening and treatment less when asymptomatic. While our findings demonstrate similarities and differences across several infectious diseases, the available data was not sufficient for a complete analysis of factors that are specific to individual diseases or to migrant sub-populations. This highlights a need for ongoing implementation research involving individual populations and diseases to address this important public health and primary care topic.

We would like to acknowledge the work of Astrid Lykke Pedersen, who contributed to the data abstraction process.
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We analyzed data on three overarching determinants of intervention uptake---values of main outcomes, acceptability, and accessibility. These are defined below:

Values of Main Outcomes of Infectious Disease Interventions: The importance placed upon the main outcomes of an intervention. These outcomes include those directly related to the disease (e.g., cure, symptom reduction, diagnosis), or costs or benefits resulting from the downstream effects of the intervention (e.g., side effects, time spent at the hospital, stigma, disclosure of disease status, cultural beliefs)

Acceptability of Infectious Disease Interventions:The willingness of the patient to request or adhere to the intervention based on their subjective attitudes and preferences towards the intervention itself or the process of receiving it (e.g., adherence challenges, social/cultural attitudes, fears about the procedure)

Accessibility of Infectious Disease Interventions:The ease with which patients use an infectious disease intervention. Determinants of accessibility include policies, community factors, healthcare service organization, or the delivery of the intervention itself.

-   Study design: Systematic reviews (qualitative or qualitative/quantitative) defined as any review that includes selection criteria, search strategy, and use of at least one database

-   Time: Published after 1 January 2010

-   Language: English language

-   Relevant to the PICO question:Population: Migrants from Low- and Middle-Income Countries residing in High-Income Countries (i.e., permanent resettlement countries)Intervention: Prevention, screening, and treatment interventions for infectious diseases (tuberculosis, hepatitis, VPDs, HIV, parasitic diseases)Comparison: No interventionOutcome: Valuation of outcomes, views about acceptability and accessibility of interventions
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Value of Outcomes.

  Citation
  -------------------------------------
    Disease
    Knowledge of Disease Status
    Behavioral Prevention
    Vaccination
    Treatment of Asymptomatic Disease
    Cure of Symptomatic Disease
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###### 

Acceptability.

  Citation
  -----------------------------------------------
  Demand-Side Determinants
    User's attitudes and Expectations
    Household attitudes and expectations
    Information on healthcare choice/providers
    Disease-related knowledge
    Intervention-related knowledge
    Stigma
    Indirect costs
    Acculturation
    SocialSupply-Side Determinants
    Characteristics of the Health Services
    Management/Staff Efficiency
    Technology
    Staff Interpersonal Skills, Including Trust
    Wages and Quality of Staff
    Language Barriers
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###### 

Accessibility.

  Citations
  --------------------------------------------------------------------
  Demand-Side Determinants
    Indirect costs to household (e.g. transport, legal status)
    Household income and willingness to pay
    Opportunity costs
    Means of transport available
    System navigation
    Low self-esteem and little assertivenessSupply-Side Determinants
    Service/household location
    Availablity of health workers, drugs, equipment
    Direct price of service, including informal fees
    Waiting time
    Unqualified health woerks, absenteeism
    Non-integration of health services
    Lack of opportunity (exclusion from services)
    Late or no referral
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###### 

Characteristics of Included Studies.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Citation                                             Years Searched                                                                 Population                                                                                                                                                                                         Intervention/Service Setting                                                                        Analysis/Synthesis Approach         EU/EEA Settings Included?   1' Study Design                                                                                                                                             \# of 1′ Studies   AMSTAR Score (/11)
  ---------------------------------------------------- ------------------------------------------------------------------------------ -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------- ----------------------------------- --------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------ --------------------
  Alvarez-del Arco et al. \[[@B20-ijerph-15-02329]\]   2005--2009                                                                     Migrants and ethnic minorities populations living in high-income countries\                                                                                                                        HIV testing and/or counselling in health and community settings                                     None specified-Narrative            Yes                         Quantitative (25); mixed-methods (2); qualitative (6); literature reviews (4)                                                                               37                 1
                                                                                                                                      Migrants were largely from sub-Saharan Africa and Latin America, (1) and other regions.                                                                                                                                                                                                                                                                                                                                                                                                                                                               

  Blondell et al. \[[@B24-ijerph-15-02329]\]           1997--2014                                                                     Foreign-born: African, particularly Sub-Saharan, and Hispanic/Latino migrants were the most studied populations.                                                                                   HIV screening, testing                                                                              None specified - narrative          Yes                         quantitative (n = 21) (descriptive/non-randomized) and qualitative (n = 10).                                                                                31                 3

  de Vries et al. \[[@B29-ijerph-15-02329]\]           2010--2017 (OECD countries); or 1990--2017 (EU, EEA, EU candidate countries)   Hard-to-reach populations including homeless, migrants, travelers (including Roma), refugees, others. 7/10 studies were of migrants only. One study included homeless, migrants, and drug users.   TB services of any kind                                                                             Thematic and content analysis       Yes                         Qualitative: Interviews (6), focus groups (2), both Interviews and Focus groups (3) multi-method participatory research (1)                                 12                 7

  Do et al. \[[@B30-ijerph-15-02329]\]                 2002--2009                                                                     Asian Americans and Pacific Islanders (69% foreign-born).                                                                                                                                          Health education, screening, and vaccination for HBV                                                None specified - narrative          No                          Cross-sectional (13); RCT (1); quasi-experimental (1); Longitudinal (1)                                                                                     20                 1

  Greenaway et al. \[[@B27-ijerph-15-02329]\]          1950 to 17 December 2008) \*                                                   Immigrants (subgroup).                                                                                                                                                                             Screening and treatment of latent TB                                                                Summary of findings table (GRADE)   Not specified               SRs (7) and guidelines (2)                                                                                                                                  9                  2

  Mitchell et al. \[[@B28-ijerph-15-02329]\]           1985--April 2011                                                               30 individual risk groups \* Data extracted from two groups only---Internally Displaced Populations (IDPs), and "Migrants/Immigration"                                                             TB screening (CXR, Mantoux TST)                                                                     Metasynthesis                       Yes                         Qualitative and Quantitative literature.                                                                                                                    21                 2

  Nguyen-Truong et al. \[[@B31-ijerph-15-02329]\]      1998--2012                                                                     Vietnamese Americans---most studies report that majority of sample are immigrants, but most aggregated immigrant and native-born.                                                                  Screening (HBV and Colorectal cancer)                                                               None specified                      No                          Descriptive (15); Interventional (2); Qualitative (3); Chart/medical record review (2); Mixed-method (1)                                                    23                 2

  Owiti et al. \[[@B25-ijerph-15-02329]\]              1970--2014 \*\*                                                                High-risk 1st- or 2nd-gen immigrants from high-prevalence countries or intermediate prevalence countries who migrated to traditionally low prevalence countries.                                   Knowledge of HBV and/or HCV infections and/or with targeted screening, vaccination, and treatment   Narrative synthesis                 Yes                         Quantitative surveys (39) and qualitative studies (11); mixed-methods (1)                                                                                   51                 6

  Pottie et al. \[[@B21-ijerph-15-02329]\]             1995--2008                                                                     Immigrants and refugees (subgroup).                                                                                                                                                                HIV Screening and treatment                                                                         Summary of findings table (GRADE)   Not specified               SRs (7) and guidelines (2)                                                                                                                                  8                  4

  Tankimovich et al. \[[@B32-ijerph-15-02329]\]        1998--2012                                                                     Homeless and immigrants with TB.                                                                                                                                                                   TB detection and treatment (active and latent)                                                      None specified---narrative          Yes                         Quantitative (17); Qualitative (5); Intervention studies (10)                                                                                               22                 2

  Tomas et al. \[[@B26-ijerph-15-02329]\]              1995--2011                                                                     Immigrants, and intra-national migrants and including migrants, asylum-seekers, refugees.                                                                                                          Screening and treatment of TB (active and latent)                                                   Meta-ethnography                    Yes                         In-depth interviews (24); focus groups (12); participant observation (5); case studies (1); Other (6) Many combined qualitative and quantitative methods.   30                 3
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\* Includes primary studies from 1995 onwards; \*\* Includes primary studies from 1999 onwards.
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###### 

Preliminary Findings from Health Belief Model Framework Analysis.

                                                                                                                                                                                                                                                                                             Main Theme                                                                                                                                                                                                                                                                                                           Reviews Cited (Lead Authors)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Disease-Specific Supporting Examples
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Knowledge of Risk Factors                                                                                                                                                                                                                                                                  Low level of knowledge of risk factors and transmission of disease may make migrants less likely to seek screening, immunization, or treatment.                                                                                                                                                                      \(5\) de Vries, Owiti, Lee, Nguyen, Blondell                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   TB:Underestimated risk of acquiring TB due to poor understanding of transmission and false beliefs, e.g. that TB is not present in US. (de Vries) HBV/HCV HBV screening is associated with better knowledge of HBV and specific modes of transmission (Owiti, Lee, Nguyen) HIV:Migrants with greater knowledge of HIV and its risk factors were more likely to be screened (Blondell)
  Perceived Susceptibility                                                                                                                                                                                                                                                                   Low perceived personal risk of acquiring an infectious disease may make migrants less likely to seek screening                                                                                                                                                                                                       \(3\) Greenaway, Pottie, Alvarez                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Perceived low risk of progressing from latent to active infection is a barrier to screening/treatment of latent TB (Greenaway)HIVLow perceived personal risk is a barrier to screening (Pottie, Alvarez)
  Perceived Severity                                                                                                                                                                                                                                                                         The severity and consequences (medical, social, economic) of diseases varied between studies, were generally well understood. However, the literature is divided on whether this is a motivating factor, or a perceived barrier to screening (i.e. risk of realizing the negative consequences through screening).   \(4\) Blondell, Lin, de Vries, Owiti)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Tuberculosis:TB was thought to be important, potentially fatal disease; participants afraid of disease's severity (Tomas)Varying perception on TB severity included: very serious, lethal disease, a long-lasting but curable disease, fear of dying from incurable disease (de Vries)HBV/HCV:Perceived outcomes of HepB and C: Poor health; discrimination/stigma; loss of income; loss of social status; liver disease (Owiti)On the other hand, belief that HBV infection is transient could lead to it not being taken seriously (Owiti)HIV:Concerns regarding the logistical consequences of living with a positive status, and fear of a future with a positive result, reduced the acceptability of screening among African migrants (Blondell)
  Perceived Benefits                                                                                                                                                                                                                                                                         Several distinct, tangible benefits to screening, vaccination, and treatment were reported by reviews, especially reassurance of negative status and prevention of spread to others.                                                                                                                                 \(4\) Tomas, Do, Pottie Blondell,                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Tuberculosis:In some communities, benefits of treating latent TB were well understood, including efficacy of medication, avoidance of stigma, and reducing risk of transmission to others (Tomas)HBV/HCV:Primary motivations for hepatitis B vaccination were protection of future health and avoidance of hepatitis B (Do)HIV:"Just wanted to find out" was a motivator among Latino migrants; "ensure they were healthy and clean" (Blondell)Refugees and refugee claimants might be reluctant to accept screening tests because they fear limited access to antiretroviral treatment and thus do not see a perceived benefit to screening (Pottie)
  Perceived Barriers                                                                                                                                                                                                                                                                         Stigma is an overarching barrier to screening and treatment that was reflected in most diseases and reviews. Stigma is also related to other perceived barriers (e.g. confidentiality issues with interpreters, hesitancy to report symptoms to family/healthcare providers)                                         \(8\) Tomas, Tankimovich, de Vries, Greenaway, Pottie, Owiti, Blondell, Alvarez,                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Tuberculosis:Feelings of stigma influenced immigrants' attitudes towards prevention and diagnosis and could prevent them from sharing relevant information with their doctors. Medical interpreters often posed a problem due to the perceived sensitivity of the information, loss of privacy, and stigmatization (Tomas)HBV/HCV:Shame and stigma of hepatitis may negatively uptake screening; may dissuade migrants from disclosing test results (Owiti)HIV:Stigma, discrimination related to HIV described as most important impediment to HIV testing, treatment (Pottie)Stigma is not significant across all studies, which may be explained by population characteristics or definitions of stigma. The few quantitative studies on stigma failed to show a statistically significant association with testing (Blondell)
  Time spent accessing healthcare can incur a significant opportunity cost on migrants, especially when they are in a precarious employment situation or do not have basic needs met in their settlement process.                                                                            \(6\) Tomas, Greenaway, de Vries, Mitchell, Blondell, Alvarez                                                                                                                                                                                                                                                        Tuberculosis:Missed days at work is a barrier to TB screening and treatment adherence (Greenaway)Reasons for refusing TB screening were predominantly a lack of time (Mitchel)HIV:Provision of rapid testing outside normal working hours may improve uptake by eliminating the opportunity cost of missed work (Blondell, Alvarez)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
  Indirect costs that may be unique to migrants can reduce the value placed on these screening and treatment interventions. The most prominent of these was that a positive test result may have a negative impact on the migrant's immigration status or refugee claim.                     \(5\) Lin, Tankimovich, Blondell, Alvarez de Vries,                                                                                                                                                                                                                                                                  Tuberculosis:Undocumented status was consistently correlated with non-adherence to treatment (Lin)Migrants may not seek treatment due to fear of revealing their illegal immigration status (Tankimovich)HIV:Migrants placed their legal status as among their highest priorities, and fears on the implications of testing positive on their visa/residency application or deportation were main barriers in several studies (Alvarez). However, this was not a barrier in all studies (Blondell)                                                                                                                                                                                                                                                                                                                                                                                             
  Factors inherent to the migration process, including language proficiency, cultural barriers, and navigation of the healthcare system, can create barriers for migrants. However, reviews reported conflicting results regarding the influence of acculturation and language proficiency   \(9\) Tomas, Lin, Do, Owiti, Pottie, Blondell, Greenaway, de Vries, Alvarez,                                                                                                                                                                                                                                         TuberculosisYears spent in host country inconsistently associated with treatment completion/outcomes. Two studies found that immigrants with better English proficiency were at increased risk of not completing treatment (Lin)Lack of familiarity with the local language was a barrier to screening (Tomas)HBV/HCVAccess to interpreter services increased odds of testing (Do, Owiti)One study reported an associated between lower English proficiency and higher likelihood of being tested for HBV, while another found that not needing an interpreter was associated with getting tested (Owiti)HIVNon-integration of health services was a key barrier to HIV screeningInability to communicate in the host country's language was a prominent barrier to screening (Pottie)While language services increase uptake, translators may introduce confidentiality concerns (Blondell)   
  Various attitudes and expectations of the intervention itself (the procedure or its side effects) may influence its acceptability among migrants                                                                                                                                           \(4\) Greenaway, Lin, Blondell, Tomas                                                                                                                                                                                                                                                                                TuberculosisBarriers to TB screening included fear of a painful test (Tomas) and venipuncture (Greenaway)Side effects are inconsistently associated with treatment adherence. Quantitative studies found no significant correlations in multivariate analysis (Lin)HIVSome African migrants felt that too much blood was taken during screening (Blondell)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
  Cues to Action                                                                                                                                                                                                                                                                             Recommendation from healthcare providers can influence healthcare seeking by migrant patients.                                                                                                                                                                                                                       \(3\) Owiti, Do, Nguyen                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        HBV/HCVRecommendation by healthcare professionals was positively associated with uptake of screening and vaccination (Owiti, Do, Nguyen)
  The importance of the patient-physician relationship was consistently emphasized. Trust, cultural sensitivity, and communication skills can act as facilitators to the acceptability of infectious disease interventions, whereas a negative relationship can serve as a barrier.          \(7\) Tomas, Greenaway, Mitchel, de Vries, Do, Nguyen, Owiti                                                                                                                                                                                                                                                         TuberculosisUsing a dedicated nurse and cultural interpreter to provide a "transcultural" approach increased screening acceptability within one year (Mitchell)Health staff can improve adherence to treatment by providing personal advice with sensitivity and "the ability to establish a personal relation on the same cultural terms". Positive relationships with health staff are perceived as "a crucial element" (Tomas)HCV/HBVPoor patient-doctor communication, and reliance on professional opinion, discouraged testing and vaccine uptake (Do, Nguyen)                                                                                                                                                                                                                                                                                                                           
  The presence of symptoms can be a necessary cue to seeking healthcare among migrants who may not understand or value the importance of treating asymptomatic disease                                                                                                                       \(5\) Tomas, Do, Blondell, de Vries, Nguyen                                                                                                                                                                                                                                                                          TBA lack of symptoms despite contact with infected persons can lead migrants to place less value on prevention and screening (Tomas)HBV/HCVApparent good health and personal preferences of migrants may discourage screening and vaccination (Do)HIVAfrican and Latin migrants reported waiting until health crises, symptoms, or being extremely sick before seeking formal healthcare (Blondell)Feeling healthy and a lack of symptoms were consistently cited as barriers to HIV screening (Blondell)                                                                                                                                                                                                                                                                                                                                                                                      
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GRADE CERQual Evidence Profile.

  Key Finding                                                                                                                                                               Studies Supporting Key Finding                                                                                                                                                                                                                                     Methodological Quality             Relevance-Research Question                             Relevance-Population                                     Coherence                                                                                                                                                                                   Adequacy-Reviews                     Adequacy-Primary Studies   Overall Assessment of Confidence   Explanation of Judgement
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ---------------------------------- ------------------------------------------------------- -------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------ -------------------------- ---------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Subjects may be reluctant to undergo screening due to negative indirect costs of having a positive result---on employment status, immigration status, and social status   \[[@B20-ijerph-15-02329],[@B21-ijerph-15-02329],[@B24-ijerph-15-02329],[@B26-ijerph-15-02329],[@B29-ijerph-15-02329],[@B32-ijerph-15-02329]\]                                                                                                                      Moderate methodological concerns   No relevance concernsFull (6/6)                         Moderate relevance concerns Full (3/6) partial (3/6)     Minor coherence concerns Coherent (5/6) Among Latino migrants in Spain, legal and administrative fears were not found to be significant barriers \[[@B29-ijerph-15-02329]\]                 Minor adequacy concerns 6 reviews    20 studies                 Low confidence                     Lack of adequate evidence, including contradictory evidence, in addition to methodological concerns among reviews reporting this finding.
  Patients value testing and treatment less if they are asymptomatic                                                                                                        \[[@B24-ijerph-15-02329],[@B26-ijerph-15-02329],[@B29-ijerph-15-02329],[@B30-ijerph-15-02329],[@B31-ijerph-15-02329]\]                                                                                                                                             Moderate methodological concerns   Minor relevance concerns Full (4/5) Indirect (1/5)      Moderate relevance concerns Full (2/5) Partial (3/5)     No coherence concerns Coherent (5/5)                                                                                                                                                        Minor adequacy concerns 5 reviews    25 studies                 Low confidence                     Methodological concerns, indirect/partial relevance of reviews supporting key finding.
  Incorrect knowledge of infectious diseases and low self-perceived risk are barriers to acceptability of screening and vaccination                                         \[[@B20-ijerph-15-02329],[@B21-ijerph-15-02329],[@B24-ijerph-15-02329],[@B25-ijerph-15-02329],[@B26-ijerph-15-02329],[@B27-ijerph-15-02329],[@B28-ijerph-15-02329],[@B29-ijerph-15-02329],[@B30-ijerph-15-02329],[@B31-ijerph-15-02329],[@B32-ijerph-15-02329]\]   Moderate methodological concerns   Minor relevance concerns Full (8/11) Indirect (3/11)    Moderate relevance concerns Full (8/11) Partial (3/11)   Minor coherence concerns Coherent (10/11) Perceiving tuberculosis as a severe disease (OR 0.29, 95% CI 0.09-0.91) was associated with refusal of TST screening \[[@B28-ijerph-15-02329]\]   Minor adequacy concerns11 reviews    81 studies                 Moderate confidence                Some reviews have significant methodological concerns, yet the key finding is consistently supported by directly relevant data in reviews with only minor methodological concerns.
  The acceptability of screening and treatment interventions is highly dependent on the cultural sensitivity and relationship with healthcare professionals                 \[[@B20-ijerph-15-02329],[@B21-ijerph-15-02329],[@B24-ijerph-15-02329],[@B25-ijerph-15-02329],[@B26-ijerph-15-02329],[@B27-ijerph-15-02329],[@B28-ijerph-15-02329],[@B29-ijerph-15-02329],[@B30-ijerph-15-02329],[@B31-ijerph-15-02329],[@B32-ijerph-15-02329]\]   Moderate methodological concerns   Minor relevance concerns Full (10/11) Indirect (1/11)   Minor relevance concerns Full (8/11) Partial (3/11)      No coherence concerns Coherent (11/11)                                                                                                                                                      Minor adequacy concerns 11 reviews   67 studies                 Moderate confidence                Supported by all reviews. Although some reviews have significant methodological concerns, reviews with few methodological concerns report directly relevant data.
  Stigma associated with infectious diseases is a barrier to the acceptability of screening interventions                                                                   \[[@B20-ijerph-15-02329],[@B21-ijerph-15-02329],[@B24-ijerph-15-02329],[@B25-ijerph-15-02329],[@B26-ijerph-15-02329],[@B27-ijerph-15-02329],[@B29-ijerph-15-02329]\]                                                                                               Moderate methodological concerns   No relevance concerns Full (7/7)                        Minor relevance concerns Full (6/7) Partial (1/7)        Minor coherence concerns Coherent (6/7) Stigma is not a significant factor in all studies. Two quantitative studies on stigma found it was not a significant deterrent to testing           Minor adequacy concerns 7 reviews    71 studies                 Moderate confidence                Well-supported by review data that is directly relevant. Direct support from reviews with few methodological concerns.

Objective: To identify, appraise and synthesize review level evidence on values and preferences for infectious disease interventions among migrants in Europe. Perspectives: Experience and attitudes of migrant population regarding ID interventions in the EU/EEA? Included programs: Reviews of programs of testing and prevention of infectious diseases in migrants where values and preferences are evaluated.
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Summary CERQual Confidence Ratings.

  Key Finding                                                                                                                                                                           CERQual Assessment Rating for Assessment of Confidence   Explanation of Confidence Rating
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Incorrect knowledge of infectious diseases and low self-perceived risk are barriers to acceptability of screening and vaccination                                                     Moderate confidence                                      Some reviews have significant methodological concerns, yet the key finding is consistently supported by directly relevant data in reviews with only minor methodological concerns.
  The acceptability of screening and treatment interventions is highly dependent on the cultural sensitivity and sense of trust in healthcare professionals and their recommendations   Moderate confidence                                      Supported by all reviews. Although some reviews have significant methodological concerns, reviews with few methodological concerns report directly relevant data.
  Stigma associated with infectious diseases is a barrier to the acceptability of screening interventions                                                                               Moderate confidence                                      Well-supported by review data that is directly relevant. Direct support from reviews with only mild methodological concerns.
  Subjects may be reluctant to undergo screening due to negative indirect costs of having a positive result---on employment status, immigration status, and social status               Low confidence                                           Lack of adequate evidence, including contradictory evidence, in addition to methodological concerns among reviews reporting this finding.
  Patients value testing and treatment less if they are asymptomatic                                                                                                                    Low confidence                                           Methodological concerns, indirect/partial relevance of reviews supporting key finding.
